Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:45am, Monday, 15'th Dec 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
First Trust Advisors LP Has $25.85 Million Position in Penumbra, Inc. $PEN
05:08am, Thursday, 11'th Dec 2025
First Trust Advisors LP lifted its holdings in shares of Penumbra, Inc. (NYSE: PEN) by 4.0% during the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 100,723 s
GMED or PEN: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 03'rd Dec 2025
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for
Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
12:33pm, Wednesday, 03'rd Dec 2025
Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
American Century Companies Inc. Has $18.64 Million Holdings in Penumbra, Inc. $PEN
03:18am, Wednesday, 03'rd Dec 2025
American Century Companies Inc. grew its holdings in Penumbra, Inc. (NYSE: PEN) by 202.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SE
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:46am, Thursday, 27'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
17 Capital Partners LLC Has $990,000 Position in Penumbra, Inc. $PEN
04:04am, Thursday, 20'th Nov 2025
17 Capital Partners LLC increased its position in shares of Penumbra, Inc. (NYSE: PEN) by 117.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Comm
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
04:30pm, Wednesday, 19'th Nov 2025
ALAMEDA, Calif. , Nov. 19, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 37th Annual Healthcare Conference on We
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 18'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
08:56am, Tuesday, 11'th Nov 2025
PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
10:45am, Monday, 10'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Spire Wealth Management Invests $91,000 in Penumbra, Inc. $PEN
03:32am, Thursday, 06'th Nov 2025
Spire Wealth Management acquired a new stake in shares of Penumbra, Inc. (NYSE: PEN) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Comm
Penumbra, Inc. (PEN) Q3 2025 Earnings Call Transcript
07:31pm, Wednesday, 05'th Nov 2025
Penumbra, Inc. ( PEN ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Cecilia Furlong Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - President Maggie Yuen - Chie
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
07:31pm, Wednesday, 05'th Nov 2025
Although the revenue and EPS for Penumbra (PEN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Str
Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates
07:01pm, Wednesday, 05'th Nov 2025
Penumbra (PEN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.85 per share a year ago.
